Ain Shams University: Kidney Diseases trials

The registry lists 16 Kidney Diseases studies with Ain Shams University as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 5Phase 3 6Phase 4 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney DiseaseRecruitingNCT06982079Phase 3
• The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus.Not yet recruitingNCT06579066Phase 2
• Clinical Outcome of Vinpocetine in Diabetic NephropathyRecruitingNCT06441591Phase 2/3
• Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients.RecruitingNCT06429345Phase 4
• Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease PatientsRecruitingNCT06421870Phase 3
• SGLT2 Adjunct in T1DCompletedNCT07591077Phase 2/3
• Resveratol in Diabetic NephropathyCompletedNCT07332819Phase 2/3
• Ameliorating Contrast Induced Nephropathy After Coronary AngiographyCompletedNCT06139952Phase 4
• The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic NephropathyCompletedNCT06115460Phase 3
• Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer PatientsStatus unknownNCT05746598
• Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis PatientsCompletedNCT05577507Phase 4
• Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3CompletedNCT05264584Not applicable
• Outcome of Glargine Insulin in Renal Impairment Patients With Diabetic KetoacidosisStatus unknownNCT05219942Not applicable
• To Assess the Effect of HDF Versus High Flux Dialysis on Free Light Chains and Cumulative Albumin Loss, in End Stage Renal Disease Patients.CompletedNCT04747067Not applicable
• Magnesium Supplementation in Diabetic NephropathyCompletedNCT03824379Phase 2
• Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 DiabetesCompletedNCT02928250Not applicable